Compound Description
| ID: C0235 | Common name: Nalorphine |
| IUPAC: (4R,4aR,7S,7aR,12bS)-3-prop-2-enyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol | CAS: CAS:62-67-9 |
| Chembl ID: CHEMBL415284 | Pubchem ID: CID:5284595 |
| Formula: C19H21NO3 | TCM-ID: TCMC1723 |
| Smiles: C=CCN1CC[C@@]23[C@@H]4[C@H]1Cc1c3c(O[C@H]2[C@H](C=C4)O)c(cc1)O | |
| Alias:
Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-(2-propenyl)-, (5α,6α)-;
Morphinan-3,6α-diol, 17-allyl-7,8-didehydro-4,5α-epoxy-; (5α,6α)-7,8-Didehydro-4,5-epoxy-17-(2-propen-1-yl)morphinan-3,6-diol; (-)-Nalorphine; Allorphine; Anarcon; Antorphin; Antorphine; Lethidrone; Letidron; Miromorfalil; N-Allylnormorphine; NANM; Nallin; Nalline; Nalorphin; Nalorphine; Norfin |
Structure:
|
Related Targets (Total: 1)
| Target id | Protein Name | Gene Symbol | Uniprot ID | Target Level | No.of Literature Evidence |
|---|---|---|---|---|---|
| T43DMF | Kappa-type opioid receptor | OPRK1 |
P41145 |
A | 1 Reference(s) |
*In this table, target level represents the quality confidence indicators of targets.
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Related Herbs (Total: 3)
Ckey description of the interaction between compound and target